Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques

Authors:

Abstract
The aim of this work was to design and test a vaccine regimen focusing the immune response on targets associated with infection prevention. We demonstrated that priming with a DNA vaccine expressing only the HIV Env V1V2 region induces Ab responses targeting the critical region in V2 associated with protection. This work shows that V1V2 scaffold DNA priming immunization provides a method to focus immune responses to the desired target region, in the absence of immune interference by other epitopes. This induced immune responses with improved recognition of epitopes important for protective immunity, namely, V2-specific humoral immune responses inversely correlating with HIV risk of infection in the RV144 trial.
Funding Information
  • HHS | NIH | National Cancer Institute (Intramural funding)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (HHSN 272201800004C)
  • Henry M. Jackson Foundation (W81XWH-18-2-0040)

This publication has 102 references indexed in Scilit: